Continual reassessment designs with early termination
From MaRDI portal
Publication:5701130
DOI10.1093/BIOSTATISTICS/3.1.87zbMath1133.62366OpenAlexW2098980231WikidataQ46316138 ScholiaQ46316138MaRDI QIDQ5701130
Publication date: 2 November 2005
Published in: Biostatistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biostatistics/3.1.87
Clinical trialSample sizeDose findingStopping rulesEarly terminationContinual reassessment methodPhase 1 designs
Applications of statistics to biology and medical sciences; meta analysis (62P10) Stopping times; optimal stopping problems; gambling theory (60G40) Optimal stopping in statistics (62L15)
Related Items (5)
A system for determining maximum tolerated dose in clinical trial ⋮ A new design of the continual reassessment method ⋮ Continual reassessment and related dose-finding designs ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ Unifying CRM and EWOC designs for phase I cancer clinical trials
This page was built for publication: Continual reassessment designs with early termination